KIAA1217 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.448800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.030800E-01
Normal-vs-Stage2
9.441400E-01
Normal-vs-Stage3
9.237000E-01
Normal-vs-Stage4
4.888600E-01
Stage1-vs-Stage2
2.104600E-01
Stage1-vs-Stage3
5.024600E-01
Stage1-vs-Stage4
3.916000E-02
Stage2-vs-Stage3
8.913600E-01
Stage2-vs-Stage4
1.400380E-01
Stage3-vs-Stage4
4.033400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.067200E-01
Normal-vs-AfricanAmerican
9.044600E-01
Normal-vs-Asian
8.860400E-01
Caucasian-vs-AfricanAmerican
8.717400E-01
Caucasian-vs-Asian
4.432600E-01
AfricanAmerican-vs-Asian
6.806800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.609600E-01
Normal-vs-Female
8.348000E-01
Male-vs-Female
9.965000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.495400E-01
Normal-vs-Age(41-60Yrs)
8.840200E-01
Normal-vs-Age(61-80Yrs)
7.898200E-01
Normal-vs-Age(81-100Yrs)
5.414600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.676800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.467400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.876000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.086590E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.077550E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.116400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.718400E-01
Normal-vs-Daily Drinker
5.094200E-01
Normal-vs-Weekly Drinker
7.217800E-01
Normal-vs-Occasional Drinker
6.934600E-01
Normal-vs-Social Drinker
9.573800E-01
Non Drinker-vs-Daily Drinker
6.602200E-01
Non Drinker-vs-Weekly Drinker
6.179700E-02
Non Drinker-vs-Occasional Drinker
8.214800E-01
Non Drinker-vs-Social Drinker
3.717200E-01
Daily Drinker-vs-Weekly Drinker
5.488500E-02
Daily Drinker-vs-Occasional Drinker
5.741200E-01
Daily Drinker-vs-Social Drinker
2.761600E-01
Weekly Drinker-vs-Occasional Drinker
1.573630E-01
Weekly Drinker-vs-Social Drinker
4.640800E-01
Occasional Drinker-vs-Social Drinker
5.593600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.515800E-01
Normal-vs-Grade 2
1.081040E-01
Normal-vs-Grade 3
9.530400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.390700E-04
Grade 1-vs-Grade 3
6.577300E-04
Grade 1-vs-Grade 4
5.515800E-01
Grade 2-vs-Grade 3
9.360800E-01
Grade 2-vs-Grade 4
1.081040E-01
Grade 3-vs-Grade 4
9.530400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.088000E-01
Normal-vs-NonDiabetic
7.707800E-01
Diabetic-vs-NonDiabetic
6.654800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.477800E-01
Normal-vs-NoPancreatitis
7.651400E-01
Pancreatitis-vs-NoPancreatitis
4.128400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.588800E-01
Normal-vs-N1
9.671400E-01
N0-vs-N1
1.502600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.068400E-01
Normal-vs-TP53-NonMutant
5.976200E-01
TP53-Mutant-vs-TP53-NonMutant
1.078050E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
